PUBLICATION
Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling
- Authors
- Major, M.B., Camp, N.D., Berndt, J.D., Yi, X., Goldenberg, S.J., Hubbert, C., Biechele, T.L., Gingras, A.C., Zheng, N., Maccoss, M.J., Angers, S., and Moon, R.T.
- ID
- ZDB-PUB-070523-22
- Date
- 2007
- Source
- Science (New York, N.Y.) 316(5827): 1043-1046 (Journal)
- Registered Authors
- Berndt, Jason, Moon, Randall T.
- Keywords
- none
- MeSH Terms
-
- Protein Binding
- Genes, Wilms Tumor
- Axin Protein
- beta Catenin/metabolism*
- beta-Transducin Repeat-Containing Proteins/metabolism
- PubMed
- 17510365 Full text @ Science
Abstract
Aberrant WNT signal transduction is involved in many diseases. In colorectal cancer and melanoma, mutational disruption of proteins involved in the degradation of beta-catenin, the key effector of the WNT signaling pathway, results in stabilization of beta-catenin and, in turn, activation of transcription. We have used tandem-affinity protein purification and mass spectrometry to define the protein interaction network of the beta-catenin destruction complex. This assay revealed that WTX, a protein encoded by a gene mutated in Wilms tumors, forms a complex with beta-catenin, AXIN1, beta-TrCP2 (beta-transducin repeat-containing protein 2), and APC (adenomatous polyposis coli). Functional analyses in cultured cells, Xenopus, and zebrafish demonstrate that WTX promotes beta-catenin ubiquitination and degradation, which antagonize WNT/beta-catenin signaling. These data provide a possible mechanistic explanation for the tumor suppressor activity of WTX.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping